126 related articles for article (PubMed ID: 1644521)
21. Serological and immunological studies with a hexane extract of Babesia bovis-infected erythrocytes.
Orinda GO; Waltisbuhl DJ; Goodger BV; Wright IG
Int J Parasitol; 1992 Aug; 22(5):677-9. PubMed ID: 1383165
[TBL] [Abstract][Full Text] [Related]
22. Blocking Babesia bovis vaccine reactions of dairy cattle in milk.
Combrink MP; Carr G; Mans BJ; Marais F
Onderstepoort J Vet Res; 2012 Dec; 79(1):E1-4. PubMed ID: 23327323
[TBL] [Abstract][Full Text] [Related]
23. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
[TBL] [Abstract][Full Text] [Related]
24. Babesia bovis: vaccination of cattle against heterologous challenge with fractions of lysate from infected erythrocytes.
Goodger BV; Commins MA; Wright IG; Mirre GB
Z Parasitenkd; 1984; 70(3):321-9. PubMed ID: 6429962
[TBL] [Abstract][Full Text] [Related]
25. Use of long-acting oxytetracycline in the immunisation of cattle against Babesia bovis and B bigemina.
Pipano E; Markovics A; Kriegel Y; Frank M; Fish L
Res Vet Sci; 1987 Jul; 43(1):64-6. PubMed ID: 3628985
[TBL] [Abstract][Full Text] [Related]
26. Protective vaccination against virulent Babesia bovis with a low-molecular-weight antigen.
Wright IG; Mirre GB; Rode-Bramanis K; Chamberlain M; Goodger BV; Waltisbuhl DJ
Infect Immun; 1985 Apr; 48(1):109-13. PubMed ID: 3980077
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of different heterologous prime-boost immunization strategies against Babesia bovis using viral vectored and protein-adjuvant vaccines based on a chimeric multi-antigen.
Jaramillo Ortiz JM; Molinari MP; Gravisaco MJ; Paoletta MS; Montenegro VN; Wilkowsky SE
Vaccine; 2016 Jul; 34(33):3913-9. PubMed ID: 27269058
[TBL] [Abstract][Full Text] [Related]
28. The development of a recombinant Babesia vaccine.
Wright IG; Casu R; Commins MA; Dalrymple BP; Gale KR; Goodger BV; Riddles PW; Waltisbuhl DJ; Abetz I; Berrie DA
Vet Parasitol; 1992 Sep; 44(1-2):3-13. PubMed ID: 1441189
[TBL] [Abstract][Full Text] [Related]
29. The pathogenicity and immunologic relationship of a virulent and a tissue-culture-adapted Babesia bovis.
Kuttler KL; Zaugg JL; Yunker CE
Vet Parasitol; 1988 Mar; 27(3-4):239-44. PubMed ID: 3285573
[TBL] [Abstract][Full Text] [Related]
30. Immunization of cattle with an inactivated polyvalent vaccine against anaplasmosis and babesiosis.
Montenegro-James S; Toro M; Leon E; Guillen AT; Lopez R; Lopez W
Ann N Y Acad Sci; 1992 Jun; 653():112-21. PubMed ID: 1626861
[No Abstract] [Full Text] [Related]
31. Search for Babesia bovis vaccine candidates.
Florin-Christensen M; Schnittger L; Dominguez M; Mesplet M; Rodríguez A; Ferreri L; Asenzo G; Wilkowsky S; Farber M; Echaide I; Suarez C
Parassitologia; 2007 May; 49 Suppl 1():9-12. PubMed ID: 17691600
[TBL] [Abstract][Full Text] [Related]
32. Successful vaccination against Boophilus microplus and Babesia bovis using recombinant antigens.
Willadsen P; Kemp DH; Cobon GS; Wright IG
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():289-94. PubMed ID: 1343705
[TBL] [Abstract][Full Text] [Related]
33. Immunization of Bos taurus steers with Babesia bovis recombinant antigens MSA-1, MSA-2c and 12D3.
Antonio Alvarez J; Lopez U; Rojas C; Borgonio VM; Sanchez V; Castañeda R; Vargas P; Figueroa JV
Transbound Emerg Dis; 2010 Apr; 57(1-2):87-90. PubMed ID: 20537116
[TBL] [Abstract][Full Text] [Related]
34. Mitigation of the response of Friesian calves to live Babesia bovis vaccine by treatment with long acting oxytetracycline.
Pipano E; Krigel Y; Markovics A; Rubinstein E; Frank M
Vet Rec; 1985 Oct; 117(16):413-4. PubMed ID: 4071930
[TBL] [Abstract][Full Text] [Related]
35. Comparison of different direct diagnostic methods to identify Babesia bovis and Babesia bigemina in animals vaccinated with live attenuated parasites.
Costa-Júnior LM; Rabelo EM; Martins Filho OA; Ribeiro MF
Vet Parasitol; 2006 Jun; 139(1-3):231-6. PubMed ID: 16580136
[TBL] [Abstract][Full Text] [Related]
36. Prospects for recombinant vaccines against Babesia bovis and related parasites.
Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
[TBL] [Abstract][Full Text] [Related]
37. Development of a Babesia bovis live attenuated vaccine.
Alonso M; Blandino T; Mendoza E; Savon L; Camacho M
Arch Med Res; 1994; 25(2):273-7. PubMed ID: 7919825
[TBL] [Abstract][Full Text] [Related]
38. Failure of a recombinant Babesia bovis antigen to protect cattle against heterologous strain challenge.
Timms P; Barry DN; Gill AC; Sharp PJ; de Vos AJ
Res Vet Sci; 1988 Sep; 45(2):267-9. PubMed ID: 3194602
[TBL] [Abstract][Full Text] [Related]
39. Heterologous strain immunity in bovine babesiosis using a culture-derived soluble Babesia bovis immunogen.
Montenegro-James S; Ristic M; Toro Benitez M; Leon E; Lopez R
Vet Parasitol; 1985 Dec; 18(4):321-37. PubMed ID: 4090242
[TBL] [Abstract][Full Text] [Related]
40. Babesia bovis RON2 contains conserved B-cell epitopes that induce an invasion-blocking humoral immune response in immunized cattle.
Hidalgo-Ruiz M; Suarez CE; Mercado-Uriostegui MA; Hernandez-Ortiz R; Ramos JA; Galindo-Velasco E; León-Ávila G; Hernández JM; Mosqueda J
Parasit Vectors; 2018 Nov; 11(1):575. PubMed ID: 30390674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
